
-
Weary border residents in Indian Kashmir struggle to survive
-
Leo XIV says Church must fight 'lack of faith' in first mass as pope
-
Liverpool boss Slot fears replacing Alexander-Arnold will be a tough task
-
British Airways owner unveils big Boeing, Airbus order
-
IPL suspended for one week over India-Pakistan conflict
-
Slot says all at Liverpool sad to see Alexander-Arnold go
-
Leo XIV celebrates first mass as pope in Sistine Chapel
-
India says repulsed fresh Pakistan attacks as death toll climbs
-
Japan's Panasonic targets 10,000 job cuts worldwide
-
Putin evokes WWII victory to rally Russia behind Ukraine offensive
-
China exports beat forecasts ahead of US tariff talks
-
Leo XIV, the 'Latin Yankee', to celebrate first mass as pope
-
Most stocks lifted by hopes for US-China talks after UK deal
-
IPL suspended indefinitely over India-Pakistan conflict: reports
-
German lender Commerzbank's profits jump as it fends off UniCredit
-
Rare bone-eroding disease ruining lives in Kenya's poorest county
-
India says repulsed fresh Pakistan attacks as de-escalation efforts grow
-
Zhao's historic snooker title sparks talk of China world domination
-
'High expectations': EU looks to Merz for boost in tough times
-
Poisoned guests rarely invited before deadly mushroom lunch, Australia trial hears
-
China sales to US slump even as exports beat forecasts
-
Indian cricket to make 'final decision' on IPL over Pakistan conflict
-
Dethroned Bundesliga champions Leverkusen face uncertain future
-
China can play hardball at looming trade talks with US: analysts
-
French monuments in trouble while PSG prepare for Champions League final
-
Newcastle face Chelsea in top five showdown, Alexander-Arnold in spotlight
-
Flick's Barca must show 'hunger' in crunch Liga Clasico
-
Clasico the last chance saloon for Ancelotti's Real Madrid
-
Timberwolves overpower Warriors to level series
-
Chinese fabric exporters anxious for US trade patch-up
-
Putin gears up to host world leaders at lavish army parade
-
Nearing 100, Malaysian ex-PM Mahathir blasts 'old world' Trump
-
Leo XIV, first US pope, to celebrate first mass as pontiff
-
Asian stocks lifted by hopes for US-China talks after UK deal
-
Former head of crypto platform Celsius sentenced 12 years
-
Ex-model testifies in NY court that Weinstein assaulted her at 16
-
Strawberry Fields REIT Announces First Quarter 2025 Operating Results
-
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference
-
Ascendant Resources Announces Closing of Second and Final Tranche of Non-Brokered Private Placement
-
Nestlé and OMP Showcase Approach to Future-Ready Supply Chain at Gartner Supply Chain Symposium/Xpo in Barcelona
-
Genflow Biosciences PLC Announces Share Subscription, Director's Dealing and Update
-
Argo Blockchain PLC Announces 2024 Annual Results and Restoration of Listing
-
'Great honor': world leaders welcome first US pope
-
Pacquiao to un-retire and fight Barrios for welterweight title: report
-
Trump unveils UK trade deal, first since tariff blitz
-
Man Utd one step away from Europa League glory despite horror season
-
Jeeno shines on greens to grab LPGA lead at Liberty National
-
Mitchell fires PGA career-low 61 to grab Truist lead
-
AI tool uses selfies to predict biological age and cancer survival
-
Extremely online new pope unafraid to talk politics

'Pharma Bro' Shkreli released to halfway house in US
So-called "Pharma bro" Martin Shkreli has been released from a Pennsylvania prison to a halfway house in New York state, the US Bureau of Prisons said Wednesday.
Shkreli, who became a poster child for predatory pharmaceutical pricing before being convicted of securities fraud in 2017, was transferred Wednesday from a low-security prison in Allenwood, Pennsylvania to undisclosed "community confinement" in New York state, said a BOP spokesperson in an email.
He is scheduled to be released from BOP's custody on September 14, the spokesperson said.
Shkreli's attorney, Benjamin Brafman, confirmed the release, saying he was "pleased" to report that his client was let out early "after completing all programs that allowed for his prison sentence to be shortened," according to a statement.
"While in the halfway house I have encouraged Mr. Shkreli to make no further statement, nor will he or I have any additional comments at this time."
Once dubbed "the most hated man in America," Shkreli, 39, became infamous for suddenly raising the price of the HIV drug Daraprim in 2015 by 5,000 percent -- from $13.50 a pill to $750.
Shkreli was originally sentenced in 2018 to seven years in prison in a fraud case not directly related to the Daraprim matter. He has been in custody since September 2017.
A.Mahlangu--AMWN